VectivBio Holding AG (VECT)vsMeridian Bioscience Inc (VIVO)
VECT
VectivBio Holding AG
$16.85
0.00%
HEALTHCARE · Cap: $1.06B
VIVO
Meridian Bioscience Inc
$2.24
-5.49%
HEALTHCARE · Cap: $1.49B
Smart Verdict
WallStSmart Research — data-driven comparison
Meridian Bioscience Inc generates 1118% more annual revenue ($333.02M vs $27.34M). VIVO leads profitability with a 12.8% profit margin vs 0.0%. VIVO earns a higher WallStSmart Score of 48/100 (D+).
VECT
Avoid25
out of 100
Grade: F
VIVO
Hold48
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for VECT.
Margin of Safety
N/A
Fair Value
$6.53
Current Price
$2.24
$4.29 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Reasonable price relative to book value
Strong operational efficiency at 22.7%
Areas to Watch
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Premium valuation, high expectations priced in
Smaller company, higher risk/reward
Revenue declined 13.8%
Earnings declined 13.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : VECT
The strongest argument for VECT centers on Debt/Equity.
Bull Case : VIVO
The strongest argument for VIVO centers on Price/Book, Operating Margin. PEG of 1.33 suggests the stock is reasonably priced for its growth.
Bear Case : VECT
The primary concerns for VECT are Revenue Growth, EPS Growth, Market Cap.
Bear Case : VIVO
The primary concerns for VIVO are P/E Ratio, Market Cap, Revenue Growth.
Key Dynamics to Monitor
VECT profiles as a value stock while VIVO is a declining play — different risk/reward profiles.
VIVO carries more volatility with a beta of 0.23 — expect wider price swings.
VECT is growing revenue faster at 0.0% — sustainability is the question.
VECT generates stronger free cash flow (54M), providing more financial flexibility.
Bottom Line
VIVO scores higher overall (48/100 vs 25/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
VectivBio Holding AG
HEALTHCARE · PHARMACEUTICALS · USA
VectivBio Holding AG, a clinical-stage biopharmaceutical company, focuses on the discovery, development and commercialization of treatments for rare conditions. The company is headquartered in Basel, Switzerland.
Visit Website →Meridian Bioscience Inc
HEALTHCARE · PHARMACEUTICALS · USA
Meridian Bioscience, Inc., a life sciences company, develops, manufactures, distributes and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases and elevated blood lead levels worldwide. The company is headquartered in Cincinnati, Ohio.
Compare with Other PHARMACEUTICALS Stocks
Want to dig deeper into these stocks?